2014
DOI: 10.1016/s0016-5085(14)60308-5
|View full text |Cite
|
Sign up to set email alerts
|

400 Cathepsin S Induces Inflammation and Pain via Biased Agonism of PAR2 and TRPV4

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Many of the studies we will review below use PAR-AP to study PAR-mediated effects, since unlike natural proteases they do not induce PARindependent effects. Among PARs, PAR 2 has a wide expression pattern (11) and has been linked to inflammation in the skin (12), gastrointestinal tract (13) and lungs (14), as well as in inflammatory pain (15).…”
Section: Introductionmentioning
confidence: 99%
“…Many of the studies we will review below use PAR-AP to study PAR-mediated effects, since unlike natural proteases they do not induce PARindependent effects. Among PARs, PAR 2 has a wide expression pattern (11) and has been linked to inflammation in the skin (12), gastrointestinal tract (13) and lungs (14), as well as in inflammatory pain (15).…”
Section: Introductionmentioning
confidence: 99%
“…Cloning of the seven-transmembrane G protein-coupled receptor (GPCR) proteaseactivated receptor 2 (PAR2) [1] allowed a detailed investigation of its role in a number of physiological and pathophysiological processes, including acute and chronic inflammation and hypersensitivity induction [2][3][4][5][6][7]. Numerous endogenous proteases target PAR2 to cleave the extracellular amino terminus at canonical cleavage sites (trypsin and mast cell tryptase) [8] to activate canonical pathways of GPCR signaling or at distinct sites (neutrophil elastase or macrophage cathepsin S) to activate the biased mechanisms [7,9,10]. Several synthetic PAR2-activating peptides (PAR2 AP) were developed, and in our experiments, we used SLIGKV-NH2, which corresponds to the tethered ligand domain and mimics the canonical mechanism of activation by the endogenous activators [11,12].…”
Section: Introductionmentioning
confidence: 99%